Improving STI prevention and management in conjunction with increasing uptake of HIV prevention products

Dr. Susan Buchbinder is the Director of Bridge HIV, a grant-funded HIV prevention research unit housed at the San Francisco Department of Public Health, and an Adjunct Professor of Medicine, Epidemiology and Biostatistics at the University of California, San Francisco. Her HIV research focuses on HIV preexposure prophylaxis, vaccines, broadly neutralizing antibodies, and strategies to support PrEP uptake and use, with a focus on addressing racial/ethnic and gender disparities. She is one of the founding members and co-chairs the Steering Committee of “Getting to Zero San Francisco,” an initiative that aims to eliminate new HIV infections, HIV-associated deaths, and HIV stigma.

Infectious disease physician at the National Institute of Cancer in Lima - Peru, since 2013.
President of the Peruvian Society of Infectious and Tropical Diseases for the period 2024 - 2026.
Director of the department of regulation, quality and national control of oncological services at the National Institue of Cancer.
Head of the Health Technology Assessment Unit at the National Institute of Cancer.
Former director of the General Directorate of Strategic Interventions in Public Health of the Ministry of Health, set 2021 - nov 2022.
International Society for Human and Animal Mycology ambassador in Peru since 2017.
His special interest is in infectious diseases in the immunocompromissed host and Global Public Health.

Dr. Susan Buchbinder is the Director of Bridge HIV, a grant-funded HIV prevention research unit housed at the San Francisco Department of Public Health, and an Adjunct Professor of Medicine, Epidemiology and Biostatistics at the University of California, San Francisco. Her HIV research focuses on HIV preexposure prophylaxis, vaccines, broadly neutralizing antibodies, and strategies to support PrEP uptake and use, with a focus on addressing racial/ethnic and gender disparities. She is one of the founding members and co-chairs the Steering Committee of “Getting to Zero San Francisco,” an initiative that aims to eliminate new HIV infections, HIV-associated deaths, and HIV stigma.

Infectious disease physician at the National Institute of Cancer in Lima - Peru, since 2013.
President of the Peruvian Society of Infectious and Tropical Diseases for the period 2024 - 2026.
Director of the department of regulation, quality and national control of oncological services at the National Institue of Cancer.
Head of the Health Technology Assessment Unit at the National Institute of Cancer.
Former director of the General Directorate of Strategic Interventions in Public Health of the Ministry of Health, set 2021 - nov 2022.
International Society for Human and Animal Mycology ambassador in Peru since 2017.
His special interest is in infectious diseases in the immunocompromissed host and Global Public Health.

I am a qualified medical doctor, currently completing a MSc in Epidemiology and Biostatistics. I currently working as a research clinician, focusing on HIV prevention and sexual and reproductive health. This includes new PrEP methodologies and vaccines for STI prevention.

Mateo Prochazka Núñez is a technical officer for HIV prevention with the World Health Organization in Geneva, Switzerland.

Mateo studied medicine in Universidad Peruana Cayetano Heredia in Lima, Peru, where he developed a passion for infectious diseases and health inequalities. He is an epidemiologist and social scientist trained at the London School of Hygiene and Tropical Medicine and the University of Washington.

Mateo has over a decade of experience in infectious disease control, spanning from HIV and other STIs to tuberculosis, NTDs, and emerging infectious diseases. During COVID-19, he supported Peru's civil society response to the pandemic, leading the redesign of the national COVID-19 mortality surveillance system. Between 2019-2022, Mateo worked with the United Kingdom Health Security Agency in STI surveillance, and led community engagement for mpox in England. Subsequently, he joined the WHO as a consultant for mpox, where he coordinated social science approaches to risk communication.

Lisa Haddad MD MS MPH is Medical Director of the Center for Biomedical Research at the Population Council and Adjunct Professor of Gynecology and Obstetrics, in division of family planning at Emory University School of Medicine. At Population Council, she leads the clinical development efforts to advance the Center’s sexual and reproductive health product portfolio, including novel contraceptive, HIV prevention and multipurpose prevention products. Dr. Haddad completed the Brigham and Women’s Hospital/Massachusetts General Hospital Integrated Residency Program in OB/GYN and her Complex Family Planning fellowship at Emory University School of Medicine. Dr. Haddad has more than 175 publications in peer-reviewed journals, several published books, and has received numerous awards for her teaching, mentorship, research, and advocacy.

Dr. Susan Buchbinder is the Director of Bridge HIV, a grant-funded HIV prevention research unit housed at the San Francisco Department of Public Health, and an Adjunct Professor of Medicine, Epidemiology and Biostatistics at the University of California, San Francisco. Her HIV research focuses on HIV preexposure prophylaxis, vaccines, broadly neutralizing antibodies, and strategies to support PrEP uptake and use, with a focus on addressing racial/ethnic and gender disparities. She is one of the founding members and co-chairs the Steering Committee of “Getting to Zero San Francisco,” an initiative that aims to eliminate new HIV infections, HIV-associated deaths, and HIV stigma.

Infectious disease physician at the National Institute of Cancer in Lima - Peru, since 2013.
President of the Peruvian Society of Infectious and Tropical Diseases for the period 2024 - 2026.
Director of the department of regulation, quality and national control of oncological services at the National Institue of Cancer.
Head of the Health Technology Assessment Unit at the National Institute of Cancer.
Former director of the General Directorate of Strategic Interventions in Public Health of the Ministry of Health, set 2021 - nov 2022.
International Society for Human and Animal Mycology ambassador in Peru since 2017.
His special interest is in infectious diseases in the immunocompromissed host and Global Public Health.

I am a qualified medical doctor, currently completing a MSc in Epidemiology and Biostatistics. I currently working as a research clinician, focusing on HIV prevention and sexual and reproductive health. This includes new PrEP methodologies and vaccines for STI prevention.

Lisa Haddad MD MS MPH is Medical Director of the Center for Biomedical Research at the Population Council and Adjunct Professor of Gynecology and Obstetrics, in division of family planning at Emory University School of Medicine. At Population Council, she leads the clinical development efforts to advance the Center’s sexual and reproductive health product portfolio, including novel contraceptive, HIV prevention and multipurpose prevention products. Dr. Haddad completed the Brigham and Women’s Hospital/Massachusetts General Hospital Integrated Residency Program in OB/GYN and her Complex Family Planning fellowship at Emory University School of Medicine. Dr. Haddad has more than 175 publications in peer-reviewed journals, several published books, and has received numerous awards for her teaching, mentorship, research, and advocacy.

Mateo Prochazka Núñez is a technical officer for HIV prevention with the World Health Organization in Geneva, Switzerland.

Mateo studied medicine in Universidad Peruana Cayetano Heredia in Lima, Peru, where he developed a passion for infectious diseases and health inequalities. He is an epidemiologist and social scientist trained at the London School of Hygiene and Tropical Medicine and the University of Washington.

Mateo has over a decade of experience in infectious disease control, spanning from HIV and other STIs to tuberculosis, NTDs, and emerging infectious diseases. During COVID-19, he supported Peru's civil society response to the pandemic, leading the redesign of the national COVID-19 mortality surveillance system. Between 2019-2022, Mateo worked with the United Kingdom Health Security Agency in STI surveillance, and led community engagement for mpox in England. Subsequently, he joined the WHO as a consultant for mpox, where he coordinated social science approaches to risk communication.